News

£100k awarded in new CRACK IT Solutions funding

New Solution: In vitro testing for subcutaneous formulations under biorelevant conditions

£200k awarded in CRACK IT Single Phase Challenges

CRACK IT Phase 1 Challenges: £600k awarded

New Solution: Ex vivo human donor retina tissue platform for disease modelling and drug development

Funding for technology partnering increases to £50k

15 February 2017

New CRACK IT Solution funding: using moth larvae to advance the 3Rs

24 January 2017

€1.8M EU funding awarded to CRACK IT Solutions provider, ZeClinics

11 January 2017

Pages